Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories
DeepChek®CE-IVD

DeepChek® Assay INTEGRASE Genotyping and Drug Resistance

Integrase

HIV-1

Overview

The DeepChek® Assay Integrase Genotyping and Drug Resistance is intended to be used for amplifying relevant portion of the human immunodeficiency virus type one (HIV-1) integrase gene from input RNA extracted from plasma, serum or whole blood samples. The codons spanning positions 20 to 280 of the integrase (INT) gene in the pol open reading frame are amplified. This nucleic acid amplification method might aid in the determination of antiviral resistance in clinical samples from HIV-infected patients. The DeepChek® INT Assay is a variant of the DeepChek® PR/RT Assay.